Hybrid workshop held on FDA campus 9/19-9/20; webcast available The Food and Drug Administration (FDA) and National Institutes of Health (NIH) are announcing a public workshop to engage with stakeholders in the implanted brain-computer interface device ecosystem. The purpose of this public workshop is to discuss implanted brain-computer interface devices and to hear from stakeholders about the development of clinical outcome assessments to evaluate the effectiveness of implanted brain-computer interfaces. Workshop Date: Thursday, September 19 and Friday, September 20, 2024 Location: Hybrid: The FDA’s White Oak Campus in Silver Spring, MD and webcast Registration Deadline: September 12, 2024 See the preliminary agenda and register for the meeting here. If you have questions about this public workshop, please contact: CDRH_BCI_Workshop2024@fda.hhs.gov.